PMA device
AMDS Hybrid Prosthesis
Artivion, Inc. · Hybrid Stent Graft, Thoracic Aortic Lesion Treatment (QSK, Class III) · First FDA decision Jun 26, 2026, newest Jun 26, 2026Aortic aneurysm and dissection
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
4
Naming "AMDS"
MAUDE reports
96
Brand "AMDS", since 2015
PubMed studies
426
Mentioning "AMDS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AMDS Hybrid Prosthesis
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P250055 · Decided Jun 26, 2026 · 179 days after receipt
Device type: Hybrid stent graft, thoracic aortic lesion treatment (QSK) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Venous Angioplasty with or without Stent Placement for the Treatment of Chronic Cerebrospinal Venous InsufficiencyLocal determinationIn effectL35028Wellpoint FederalUpdated Jul 14, 2026
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39938CGS Administrators, LLCUpdated Jun 19, 2026
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39944Noridian Healthcare Solutions, LLCUpdated Jan 12, 2026
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39989WPS Insurance CorporationUpdated Jun 25, 2025
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39933Palmetto GBAUpdated Jun 25, 2025
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "AMDS", any status and sponsor, newest update first.
- Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I DissectionActive, not recruiting
JOTEC GmbHNot on our public-company list
NCT03894033 · 301 participants · Start Mar 12, 2019 · Primary completion Jun 30, 2026
Device: Ascyrus Medical Dissection Stent (AMDS) · For: Aortic Dissection; Acute DeBakey I Dissection; Acute Type A Dissection and 1 more
Sites: Berlin, Germany
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AMDS", and for the whole product code for context.
This brand
96 reports: 0 malfunction, 94 injury, 2 death
Whole product code QSK
346 reports: 34 malfunction, 277 injury, 35 death
Newest reports for this brand
1063481-2026-00043 · Received Oct 14, 2026 · Event dated Aug 28, 2024
Device type: Hybrid Stent Graft, Thoracic Aortic Lesion Treatment (QSK)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Reaction to Medicinal Component of Device
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AMDS"[tiab]. The summary above synthesizes these.
- Antimicrobial prescribing during telemedicine appointments.
Haverkate M, Evans M, Walter EJS · Open Vet J · 2024
- The AMDS Stent Reduces Postoperative Distal Anastomotic New Re-Entry (DANE) Tears, But Will It Reduce the Need for Late Aortic Reintervention?
Lawrence KM, Desai N · Can J Cardiol · 2024Editorial, Comment
- amdS as a dominant recyclable marker in Cryptococcus neoformans.
Erpf PE, Stephenson CJ, Fraser JA · Fungal Genet Biol · 2019Research Support, Non-U.S. Gov't
- Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration.
Tang S, Yang J, Xiao B, et al. · Invest Ophthalmol Vis Sci · 2024Review, Research Support, Non-U.S. Gov't
- An amdS-lacZ fusion for studying gene regulation in Aspergillus.
Davis MA, Cobbett CS, Hynes MJ · Gene · 1988Research Support, Non-U.S. Gov't
- Breastfeeding and migraine drugs.
Davanzo R, Bua J, Paloni G, et al. · Eur J Clin Pharmacol · 2014Review
- Thoraflex Hybrid vs. AMDS: To replace the arch or to stent it in type A aortic dissection?
Al-Tawil M, Jubouri M, Tan SZ, et al. · Asian Cardiovasc Thorac Ann · 2023Review
- Allyl methyl disulfide (AMDS) prevents N,N-dimethyl formamide-induced liver damage by suppressing oxidative stress and NLRP3 inflammasome activation.
Li LX, Wang L, Wang S, et al. · Food Chem Toxicol · 2023
- Reduced Nicotine Cigarettes and E-Cigarettes in High-Risk Populations: 3 Randomized Clinical Trials.
Higgins ST, Sigmon SC, Tidey JW, et al. · JAMA Netw Open · 2024Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.
- Monkeypox diagnosis using ensemble classification.
Rabie AH, Saleh AI · Artif Intell Med · 2023
- Regulatory circuits of the amdS gene of Aspergillus nidulans.
Hynes MJ · Antonie Van Leeuwenhoek · 1994Research Support, Non-U.S. Gov't, Review
- Longitudinal Recovery Following Repetitive Traumatic Brain Injury.
Etemad LL, Yue JK, Barber J, et al. · JAMA Netw Open · 2023Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code QSK.
- Thoraflex HybridVascutek, Ltd. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.